Impact of DNA mutations on blood cell production uncovered
Research highlights, Science Researchers discover how DNA mutations change blood cell production and how this relates to ageing and cancer development.
2022
research-highlightsscience
Genome sequencing accelerates cancer detection
Science The Gerstung Group at EMBL-EBI and collaborators have developed a statistical model that analyses genomic data to predict whether a patient has a high or low risk of developing oesophageal cancer.
2020
science
Artificial intelligence finds patterns of mutations and survival in tumour images
Science Researchers have developed an artificial intelligence algorithm that uses computer vision to analyse tissue samples from cancer patients. The algorithm can distinguish between healthy and cancerous tissues, and can also identify patterns DNA and RNA changes in tumours.
2020
science
DNA damage and faulty repair jointly cause mutations
Science DNA mutations are caused by a combination of DNA damage and repair, shows study by EMBL-EBI and collaborators.
2020
science
The Pan-Cancer project
Science EMBL co-leads most comprehensive study of genetic causes of cancer
2020
science
Cancer mutations occur decades before diagnosis
Science Researchers at EMBL’s European Bioinformatics Institute (EMBL-EBI) and the Francis Crick Institute have analysed the whole genomes of over 2600 tumours from 38 different cancer types to determine the chronology of genomic changes during cancer development.
2020
science
Leukaemia roots detectable years before diagnosis
Science Acute myloid leukaemia risk could be detected years before diagnosis
2018
science
New insights into the origins of cancer
Science What worms can tell us about cancer
2018
science
Welcome: Moritz Gerstung
Lab Matters New group explores why patients with same cancer exhibit unique constellations of genetic mutations.
2015
lab-matters
No matching posts found
